Cite Filings / SYRE / 0000950170-23-069037
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
3/A

Filing

Spyre Therapeutics, Inc. · Filed 2023-12-08 · Acc 0000950170-23-069037

Documents 1

  • 3/A , xslF345X02/ownership.xml

Around this filing

  • 2023-12-11 SC 13D/A Beneficial Ownership Report
  • 2023-12-11 4 Options or other derivatives
  • 2023-12-08 424B3 Prospectus
  • 2023-12-08 8-K Material agreement · Unregistered share sale · Bylaws or fiscal year change · Regulation FD disclosure
  • 2023-12-08 4/A Director acquired 34,360 shares (conversion)
  • 2023-12-08 3/A 3/A
  • 2016-04-14 3/A 3/A

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslF345X02/ownership.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…